Healthcare -
Drug Manufacturers - General - NYSE - US
$ 211.93
1.39 %
$ 374 B
Market Cap
89.05
P/E
ABBV - COST OF REVENUE
Cost of Revenue ABBV - AbbVie Inc.
16.9 B
LAST VALUE
-1.48%
2 YEAR CAGR
17.84%
5 YEAR CAGR
14.34%
10 YEAR CAGR